Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Aged (2)
- Aged, 80 and over (2)
- Dementia (2)
- Female (2)
- Humans (2)
-
- Male (2)
- *Homes for the Aged (1)
- *Medical Futility (1)
- *Nursing Homes (1)
- Alzheimer Disease (1)
- Cohort Studies (1)
- Comorbidity (1)
- Cross-Sectional Studies (1)
- Disease Progression (1)
- Drug Substitution (1)
- Drug Utilization (1)
- Health Services Misuse (1)
- Hospice Care (1)
- Hydroxymethylglutaryl-CoA Reductase Inhibitors (1)
- Inappropriate Prescribing (1)
- Mental Status Schedule (1)
- Nursing Homes (1)
- Odds Ratio (1)
- Retrospective Studies (1)
- Terminal Care (1)
- United States (1)
Articles 1 - 6 of 6
Full-Text Articles in Medicine and Health Sciences
Scramble Or Script: Responding To New Medicare Billing For Medications In Hospice, Jennifer Tjia, Shaida Talebreza, Maija Reblin, Anna Beck, Lee Ellington
Scramble Or Script: Responding To New Medicare Billing For Medications In Hospice, Jennifer Tjia, Shaida Talebreza, Maija Reblin, Anna Beck, Lee Ellington
Jennifer Tjia
No abstract provided.
Use Of Medications Of Questionable Benefit In Advanced Dementia, Jennifer Tjia, Becky Briesacher, Daniel Peterson, Qin Liu, Susan Andrade, Susan Mitchell
Use Of Medications Of Questionable Benefit In Advanced Dementia, Jennifer Tjia, Becky Briesacher, Daniel Peterson, Qin Liu, Susan Andrade, Susan Mitchell
Jennifer Tjia
IMPORTANCE: Advanced dementia is characterized by severe cognitive impairment and complete functional dependence. Patients' goals of care should guide the prescribing of medication during such terminal illness. Medications that do not promote the primary goal of care should be minimized. OBJECTIVES: To estimate the prevalence of medications with questionable benefit used by nursing home residents with advanced dementia, identify resident- and facility-level characteristics associated with such use, and estimate associated medication expenditures. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional study of medication use by nursing home residents with advanced dementia using a nationwide long-term care pharmacy database linked to the Minimum Data …
Use Of Atypical Antipsychotics In Nursing Homes And Pharmaceutical Marketing, Camilla Pimentel, Jennifer Donovan, Terry Field, Jerry Gurwitz, Leslie Harrold, Abir Kanaan, Celeste Lemay, Kathleen Mazor, Jennifer Tjia, Becky Briesacher
Use Of Atypical Antipsychotics In Nursing Homes And Pharmaceutical Marketing, Camilla Pimentel, Jennifer Donovan, Terry Field, Jerry Gurwitz, Leslie Harrold, Abir Kanaan, Celeste Lemay, Kathleen Mazor, Jennifer Tjia, Becky Briesacher
Jennifer Tjia
OBJECTIVES: To describe the current extent and type of pharmaceutical marketing in nursing homes (NHs) in one state and to provide preliminary evidence for the potential influence of pharmaceutical marketing on the use of atypical antipsychotics in NHs.
DESIGN: Nested mixed-methods, cross-sectional study of NHs in a cluster randomized trial.
SETTING: Forty-one NHs in Connecticut.
PARTICIPANTS: NH administrators, directors of nursing, and medical directors (n = 93, response rate 75.6%).
MEASUREMENTS: Quantitative data, including prescription drug dispensing data (September 2009-August 2010) linked with Nursing Home Compare data (April 2011), were used to determine facility-level prevalence of atypical antipsychotic use, facility-level …
Rationales That Providers And Family Members Cited For The Use Of Antipsychotic Medications In Nursing Home Residents With Dementia, Alice Bonner, Terry Field, Celeste Lemay, Kathleen Mazor, Daniel Andersen, Christina Compher, Jennifer Tjia, Jerry Gurwitz
Rationales That Providers And Family Members Cited For The Use Of Antipsychotic Medications In Nursing Home Residents With Dementia, Alice Bonner, Terry Field, Celeste Lemay, Kathleen Mazor, Daniel Andersen, Christina Compher, Jennifer Tjia, Jerry Gurwitz
Jennifer Tjia
OBJECTIVES: To describe the rationales that providers and family members cite for the use of antipsychotic medications in people with dementia living in nursing homes (NHs). DESIGN: Qualitative, descriptive study. SETTING: Twenty-six medium-sized and large facilities in five Centers for Medicare and Medicaid Services regions. PARTICIPANTS: Individuals diagnosed with dementia who received an antipsychotic medication. MEASUREMENTS: Data were collected from medical record abstraction and interviews with prescribers, administrators, direct care providers, and family members. Textual data from medical record abstraction and responses to open-ended interview questions were analyzed using directed content analysis techniques. A coding scheme was developed, and coded …
Statin Discontinuation In Nursing Home Residents With Advanced Dementia, Jennifer Tjia, Sarah Cutrona, Daniel Peterson, George Reed, Susan Andrade, Susan Mitchell
Statin Discontinuation In Nursing Home Residents With Advanced Dementia, Jennifer Tjia, Sarah Cutrona, Daniel Peterson, George Reed, Susan Andrade, Susan Mitchell
Jennifer Tjia
OBJECTIVES: To describe patterns of, and factors associated with, statin use and discontinuation in nursing home (NH) residents progressing to advanced dementia and followed for at least 90 days.
DESIGN: Retrospective inception cohort using a dataset linking 2007 to 2008 Minimum Data Set (MDS) to Medicare denominator and Part D files.
SETTING: All NHs in five states (Minnesota, Massachusetts, Pennsylvania, California, Florida).
PARTICIPANTS: NH residents with dementia.
MEASUREMENTS: Residents who developed advanced dementia were observed from baseline (date of progression to very severe cognitive impairment with eating problems) and followed for at least 90 days to statin discontinuation or death. …
Appropriateness Of Psychopharmaco-Logical Medication, Kate Lapane, Jacob Hunnicutt, Jennifer Tjia
Appropriateness Of Psychopharmaco-Logical Medication, Kate Lapane, Jacob Hunnicutt, Jennifer Tjia
Jennifer Tjia
No abstract provided.